Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novo Nordisk/Boehringer Ingelheim collaboration discovers new series of H3 receptor antagonists

Dec. 1, 2000

Tri- and di-aryl acid PPAR modulators claimed by Aventis for diabetes and related disorders

Nov. 29, 2000

Successful completion of Alkermes' first clinical trial with inhaled insulin

Nov. 29, 2000

8th UEGW news: alendronate is safe and effective for increasing BMD in Crohn's disease

Nov. 29, 2000

Novel, steroidal, tissue-selective estrogens disclosed by Schering AG

Nov. 28, 2000

Lead candidate selected in Roche/Vernalis obesity collaboration

Nov. 28, 2000

Novel class of H3 antagonists identified through Novo Nordisk/Boehringer Ingelheim collaboration

Nov. 27, 2000

Novel pharmaceutical compositions prepared for rosiglitazone

Nov. 27, 2000

Vivus signs Muse marketing agreement with Paladin for Canada

Nov. 27, 2000

Novo Nordisk presents new series of PPAR-activating compounds for diabetes and obesity

Nov. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
EASL spotlight: TUNE-401 advances epigenetic silencing in HBV
BioWorld
Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...